These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 31191864)
1. How mithramycin stereochemistry dictates its structure and DNA binding function. Hou C; Rohr J; Parkin S; Tsodikov OV Medchemcomm; 2019 May; 10(5):735-741. PubMed ID: 31191864 [TBL] [Abstract][Full Text] [Related]
2. Dimerization and DNA recognition rules of mithramycin and its analogues. Weidenbach S; Hou C; Chen JM; Tsodikov OV; Rohr J J Inorg Biochem; 2016 Mar; 156():40-7. PubMed ID: 26760230 [TBL] [Abstract][Full Text] [Related]
3. Structures of mithramycin analogues bound to DNA and implications for targeting transcription factor FLI1. Hou C; Weidenbach S; Cano KE; Wang Z; Mitra P; Ivanov DN; Rohr J; Tsodikov OV Nucleic Acids Res; 2016 Oct; 44(18):8990-9004. PubMed ID: 27587584 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of c-src transcription by mithramycin: structure-activity relationships of biosynthetically produced mithramycin analogues using the c-src promoter as target. Remsing LL; Bahadori HR; Carbone GM; McGuffie EM; Catapano CV; Rohr J Biochemistry; 2003 Jul; 42(27):8313-24. PubMed ID: 12846580 [TBL] [Abstract][Full Text] [Related]
5. Mithramycin SK, a novel antitumor drug with improved therapeutic index, mithramycin SA, and demycarosyl-mithramycin SK: three new products generated in the mithramycin producer Streptomyces argillaceus through combinatorial biosynthesis. Remsing LL; González AM; Nur-e-Alam M; Fernández-Lozano MJ; Braña AF; Rix U; Oliveira MA; Méndez C; Salas JA; Rohr J J Am Chem Soc; 2003 May; 125(19):5745-53. PubMed ID: 12733914 [TBL] [Abstract][Full Text] [Related]
6. Solution structure of the mithramycin dimer-DNA complex. Sastry M; Patel DJ Biochemistry; 1993 Jul; 32(26):6588-604. PubMed ID: 8329387 [TBL] [Abstract][Full Text] [Related]
7. The antitumor antibiotic mithramycin: new advanced approaches in modification and production. Kormanec J; Novakova R; Csolleiova D; Feckova L; Rezuchova B; Sevcikova B; Homerova D Appl Microbiol Biotechnol; 2020 Sep; 104(18):7701-7721. PubMed ID: 32686008 [TBL] [Abstract][Full Text] [Related]
8. Semi-synthetic mithramycin SA derivatives with improved anticancer activity. Scott D; Chen JM; Bae Y; Rohr J Chem Biol Drug Des; 2013 May; 81(5):615-24. PubMed ID: 23331575 [TBL] [Abstract][Full Text] [Related]
9. Discovery of a Cryptic Intermediate in Late Steps of Mithramycin Biosynthesis. Wheeler R; Yu X; Hou C; Mitra P; Chen JM; Herkules F; Ivanov DN; Tsodikov OV; Rohr J Angew Chem Int Ed Engl; 2020 Jan; 59(2):826-832. PubMed ID: 31702856 [TBL] [Abstract][Full Text] [Related]
10. Novel GC-rich DNA-binding compound produced by a genetically engineered mutant of the mithramycin producer Streptomyces argillaceus exhibits improved transcriptional repressor activity: implications for cancer therapy. Albertini V; Jain A; Vignati S; Napoli S; Rinaldi A; Kwee I; Nur-e-Alam M; Bergant J; Bertoni F; Carbone GM; Rohr J; Catapano CV Nucleic Acids Res; 2006; 34(6):1721-34. PubMed ID: 16571899 [TBL] [Abstract][Full Text] [Related]
11. Solution structure of mithramycin dimers bound to partially overlapping sites on DNA. Sastry M; Fiala R; Patel DJ J Mol Biol; 1995 Sep; 251(5):674-89. PubMed ID: 7666419 [TBL] [Abstract][Full Text] [Related]
12. Bioanalytical method for quantitative determination of mithramycin analogs in mouse plasma by HPLC-QTOF. Eckenrode JM; Mitra P; Rohr J; Leggas M Biomed Chromatogr; 2019 Aug; 33(8):e4544. PubMed ID: 30927450 [TBL] [Abstract][Full Text] [Related]
14. Mithramycin analogues generated by combinatorial biosynthesis show improved bioactivity. Baig I; Perez M; Braña AF; Gomathinayagam R; Damodaran C; Salas JA; Méndez C; Rohr J J Nat Prod; 2008 Feb; 71(2):199-207. PubMed ID: 18197601 [TBL] [Abstract][Full Text] [Related]
15. Interaction of mithramycin with DNA. Evidence that mithramycin binds to DNA as a dimer in a right-handed screw conformation. Demicheli C; Albertini JP; Garnier-Suillerot A Eur J Biochem; 1991 Jun; 198(2):333-8. PubMed ID: 1828228 [TBL] [Abstract][Full Text] [Related]
16. Association of antitumor antibiotic Mithramycin with Mn2+ and the potential cellular targets of Mithramycin after association with Mn2+. Dutta S; Lahiri S; Banerjee A; Saha S; Dasgupta D J Biomol Struct Dyn; 2015; 33(2):434-46. PubMed ID: 24559512 [TBL] [Abstract][Full Text] [Related]
17. Nano-Encapsulation of Mithramycin in Transfersomes and Polymeric Micelles for the Treatment of Sarcomas. Estupiñán Ó; Rendueles C; Suárez P; Rey V; Murillo D; Morís F; Gutiérrez G; Blanco-López MDC; Matos M; Rodríguez R J Clin Med; 2021 Mar; 10(7):. PubMed ID: 33806182 [TBL] [Abstract][Full Text] [Related]
18. The three-dimensional structure of the 4:1 mithramycin:d(ACCCGGGT)(2) complex: evidence for an interaction between the E saccharides. Keniry MA; Owen EA; Shafer RH Biopolymers; 2000 Aug; 54(2):104-14. PubMed ID: 10861371 [TBL] [Abstract][Full Text] [Related]
19. Enzyme immunoassay for the quantification of mithramycin using beta-D-galactosidase as a label. Fujiwara K; Saita T; Nakashima K; Kitagawa T Cancer Res; 1986 Mar; 46(3):1084-8. PubMed ID: 2935248 [TBL] [Abstract][Full Text] [Related]
20. Binding of (MTR)2Zn2+ complex to chromatin: a comparison with (MTR)2Mg2+ complex. Das S; Dasgupta D J Inorg Biochem; 2005 Mar; 99(3):707-15. PubMed ID: 15708791 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]